ERT

Joshua Boger joins Alkeus Pharmaceuticals as executive chairman

Friday, May 25, 2012 01:21 PM

Alkeus Pharmaceuticals of Boston, Mass., has appointed Joshua Boger, Ph.D., as executive chairman of the company's board of directors. 

More... »

Intertek launches cGMP cell based assay services

Wednesday, April 4, 2012 10:08 AM

Intertek, a quality and safety solutions provider, has launched cGMP compliant cell based assay services for biologic therapeutics in its European Centre of Excellence for Biopharmaceuticals at Manchester, U.K.

More... »

Certara acquires Simcyp, adding preclinical research capability

Thursday, March 1, 2012 11:00 AM

Certara, a provider of drug discovery and development software and scientific consulting services, will acquire U.K-based Simcyp, a research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations.

More... »

ERT launches new corporate web site

Wednesday, February 15, 2012 03:52 PM

ERT, a global technology-driven provider of health outcomes services and customizable medical devices, has launched a new corporate web site.

More... »

FDA approves Kalydeco to treat rare form of cystic fibrosis

Friday, February 3, 2012 01:46 PM

The FDA has approved Kalydeco (ivacaftor), manufactured by Vertex Pharmaceuticals, for the treatment of a rare form of cystic fibrosis in patients ages six and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.

More... »

Covance enters R&D collaboration

Thursday, January 19, 2012 08:30 AM

Covance, Inserm Transfert, a subsidiary of Inserm, and seed investment company Inserm Transfert Initiative have signed a four-year R&D collaboration.

More... »

Icon boosts its presence in Asia with acquisition of Chinese CRO BeijingWits Medical Consulting

Monday, December 19, 2011 10:13 AM

Now that many mid-tier CROs have been acquired by either equity investment firms or other CROs and the trend has slowed, a new form of consolidation is emerging. Robust CROs are rounding out their offerings with small but strategic acquisitions to make them bigger, stronger and more complete. The ultimate goal: to continue winning lucrative strategic outsourcing agreements from sponsors.  

More... »

Gilead Sciences acquires Pharmasset, looks to duplicate its HIV success in hepatitis C

Monday, November 28, 2011 08:02 AM

Consolidation among drug sponsors continues. 

More... »

CertiVox wins 2011 Bully Award

Tuesday, October 25, 2011 01:43 PM

CertiVox has received the Yearling category of the 2011 Bully Award, an honor presented by White Bull Summits to Europe’s leading technology, media and telecommunications companies.

More... »

Cytonet’s SELICA III trial expands to Canada

Wednesday, October 19, 2011 10:58 AM

Canadian health authority, Health Canada, recently granted Cytonet approval to extend the SELICA III trial, which has been open in the United States since 2010, into Canada.

More... »